A carregar...

Engineered Hydrogels for Local and Sustained Delivery of RNA-Interference Therapies

It has been nearly two decades since RNA-interference (RNAi) was first reported. While there are no approved clinical uses, several promising phase II and III clinical trials suggest the great promise of RNAi therapeutics. One challenge for RNAi therapies is the controlled localization and sustained...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Adv Healthc Mater
Main Authors: Wang, Leo L., Burdick, Jason A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5226889/
https://ncbi.nlm.nih.gov/pubmed/27976524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/adhm.201601041
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!